Dr. Margarita Cuervas-Mons | Farmacoterapia Pediatrica

Dr. Margarita Cuervas-Mons : Leading Researcher in Farmacoterapia Pediatrica

Dr. Margarita Cuervas-Mons, Hospital Infantil Universitario Niño Jesús, Spain

🎉 Congratulations, Dr. Margarita Cuervas-Mons!

🏆 On behalf of ScienceFather, we celebrate your remarkable achievement in winning the prestigious Best Researcher Award! Your dedication, innovative research, and scholarly contributions have left an indelible mark in your field. 🌟 Your commitment to advancing knowledge and pushing the boundaries of research is truly commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. ✨

🌟 He highly accomplished professional with a Doctorate earned with honors, “cum laude,” from the Autonomous University of Madrid in 2007. Her expertise as a Pharmaceutical Specialist in Hospital Pharmacy was cultivated at the University Clinical Hospital of Valladolid from July 2000 to July 2004. Additionally, He achieved an Advanced Studies Diploma in Cellular Biology and Pharmacology from the University of Valladolid between September 2000 and June 2002. Her academic journey commenced with a Bachelor’s Degree in Pharmacy from the Complutense University of Madrid in the graduating class of ’94-’99. 🌟

🌐 Professional Profiles :  Scopus 

👩‍🏫 Teaching and Research Activities :

  • 🌟 Collaborating researcher in the Spanish Registry Study of Pharmacotherapy Studies against COVID-19 (RERFAR), under AEMPS SEF-LOP-2020-02 code. 🦠🧪
  • 🌟 Principal investigator of the project: Multicenter Study of Medication Reconciliation at Admission in Pediatric Chronic Patients: Searching for an Algorithm as a Tool, selected in the SEFH Working Groups Research Grants Call in 2019. 🏥📚
  • 🌟 Project director of the research: Impact of Medication Reconciliation on the Reduction of Medication-Related Problems in Pediatric Patients Admitted to a Hospital. Pharmacy Service at Niño Jesús Children’s Hospital. January 2018 to January 2019. 💊📊
  • 🌟 Co-directing a doctoral thesis titled: Use of Omega-3 Fatty Acids in Parenteral Nutrition in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation, conducted at Niño Jesús University Children’s Hospital. Faculty of Medicine. Autonomous University of Madrid. September 2017. 🎓🍏
  • 🌟 Co-directing a doctoral thesis titled: Pharmaceutical Care in a Home Hospitalization Unit for Pediatric Palliative Care, conducted at Niño Jesús University Children’s Hospital. Faculty of Pharmacy. Complutense University of Madrid. November 2020. 💊🏠
  • 🌟 Associate Professor at the Faculty of Pharmacy, University of Alcalá de Henares. Responsible for supervised internship students from the academic year 2007-2008 to 2017-2018. 🎓🤝
  • 🌟 Keep up the excellent work in advancing research and education! 🚀
📚 Publication Impact and Citations:

Scopus Metrics:

  • 📝 Publications: 10 documents indexed in Scopus.
  • 📊 Citations: A total of 51 citations for his publications, reflecting the widespread impact and recognition of Dr. Margarita Cuervas’s research within the academic community.

Publications ( Top Note ) :

1.  Multicentre study of medication reconciliation in paediatric onco-hematology

2.  Medication reconciliation on admission in paediatric chronic patients: A multicentre study

3.  Criteria for the selection of paediatric patients susceptible to reconciliation error

4.  Off-Label and Unlicensed Drugs in Pediatric Palliative Care: A Prospective Observational Study

5.  Medication reconciliation upon admission in paediatric hospital setting: preliminary data

6.  Use of carglumic acid in valproate-induced hyperammonemia: 25 pediatric cases

7.  Participation of the pharmacist in adjusting vancomycin treatment in a pediatric intensive care unit

8.  Ordering and standardisation of pediatric parenteral nutrition

9.  Pediatric parenteral nutrition: Clinical practice guidelines from the Spanish Society of Parenteral and Enteral Nutrition (SENPE), the Spanish Society of Pediatric Gastroenterology, Hepatology and Nutrition (SEGHNP) and the Spanish Society of Hospital Pharmacy (SEFH)

10.  Potential validity of thermolabile drugs outside the preservation conditions recommended by the manufacturer

 

May your efforts cultivate a future where the skies are not only filled with innovation but are also fortified against the challenges that technological progress may bring.

Wishing you continued success in your endeavors to secure the future of Network Protocols, Technology and Communication.